"The overall science and technology objective of this programme is to determine if engineered nanoparticles could constitute a significant neuro-toxicological risk to humans for two diseases - Alzheimer's and Parkinson's," said Professor Howard.
Other universities that are a part of the project include those of Dublin, Cork, Munich and Edinburgh as well as universities of California, Rochester and Rice and the Japanese Institute of Materials Science.
Source: Medindia
RAS